{"nct_id":"NCT05005273","title":"A Study to Assess BMS-986207 in Combination With Nivolumab and Ipilimumab as First-line Treatment for Participants With Stage IV Non-Small Cell Lung Cancer","status":"COMPLETED","status_verified_date":"2024-01","start_date":"2022-10-03","start_date_type":"ACTUAL","primary_completion_date":"2022-12-27","primary_completion_date_type":"ACTUAL","completion_date":"2022-12-27","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["BMY"]}